1125P Identification of a subset of metastatic melanoma patients demonstrating germline determined insensitivity to immunotherapy
Fairfax, B.P., Taylor, C., Watson, R.A., Ye, W., Tong, O., Matos Santo, F., Coupe, N.A., Middleton, M.R., Payne, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
135P The lymphocyte stability index (LSI) forms a pan-cancer peripheral biomarker for overall survival post initiation of immune checkpoint blockade (ICB)
Watson, R.A., Tong, O., Taylor, C., Vallance, G., Matos Santo, F., Little, M., Sun, B., Shine, B., Middleton, M.R., Coupe, N.A., Payne, M., Fairfax, B.P.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
155P The molecular basis of the lymphocyte stability index (LSI): A pan-cancer peripheral biomarker for survival post immune checkpoint blockade (ICB)
Watson, R., Tong, O., Little, M., Muldoon, D., Mackay, S., Oluwafemi, A-A., Sun, S., Milotay, G., Taylor, C., Vallance, G., Shine, B., Middleton, M.R., Coupe, N.A., Payne, M., Fairfax, B.P.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1502TiP A phase I/IIa trial of ChAdOx1 and MVA vaccines against MAGE-A3 and NY-ESO-1
Blackhall, F., Moliner, L., Samson, A., Franks, K., Karydis, I., Joseph-Pietras, D., Frank, O., Lavender, H., Jannoo, M., Marshall, M., Motteram, P., van den Eynde, B.J., Leung, C., Hill, A., Middleton, M.R., Coupe, N.A., Steele, N., Spicer, J., Shaw, P.H., Symeonides, S.N.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article